# Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases

> **NCT02709811** · PHASE1,PHASE2 · TERMINATED · sponsor: **IGEA** · enrollment: 5 (actual)

## Conditions studied

- Colorectal Adenocarcinoma

## Interventions

- **DRUG:** Electrochemotherapy

## Key facts

- **NCT ID:** NCT02709811
- **Lead sponsor:** IGEA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Enrollment at study center below rate compatible with study completion.
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709811, "Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02709811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*